Evidence map›Paper›PMID 36431805›Full record

ArticleMolecules (Basel, Switzerland)2022

Camel Grass Phenolic Compounds: Targeting Inflammation and Neurologically Related Conditions.

Graciliana Lopes, Elisabete Gomes, Mariana Barbosa, João Bernardo, Patrícia Valentão

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Graciliana LopesREQUIMTE/LAQV, Laboratory of Pharmacognosy, Department of Chemistry, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira, n° 228, 4050-313 Porto, Portugal.ORCID 0000-0002-7764-474X
Elisabete GomesREQUIMTE/LAQV, Laboratory of Pharmacognosy, Department of Chemistry, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira, n° 228, 4050-313 Porto, Portugal.
Mariana BarbosaREQUIMTE/LAQV, Laboratory of Pharmacognosy, Department of Chemistry, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira, n° 228, 4050-313 Porto, Portugal.
João BernardoREQUIMTE/LAQV, Laboratory of Pharmacognosy, Department of Chemistry, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira, n° 228, 4050-313 Porto, Portugal.
Patrícia ValentãoREQUIMTE/LAQV, Laboratory of Pharmacognosy, Department of Chemistry, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira, n° 228, 4050-313 Porto, Portugal.ORCID 0000-0002-0740-4396
Universidade do Porto · PT

Funding

European Union NORTE-01-0145-FEDER-000024Fundação para a Ciência e Tecnologia UID/QUI/50006/2013
6 · The paper itself

Abstract

backgroundThe use of plants for therapeutic purposes has been supported by growing scientific evidence.

methodsThis work consisted of (i) characterizing the phenolic compounds present in both aqueous and hydroethanol (1:1,

resultsSeveral caffeic acid and flavonoid derivatives were determined in both extracts. The extracts displayed scavenging capacity against the physiologically relevant nitric oxide (

conclusionsThis study reports, for the first time, the potential medicinal properties of aqueous and hydroethanol extracts of camel grass in the RAW 264.7 cell model of inflammation, and in neurologically related conditions.

Indexed as

ButyrylcholinesteraseCamelusAcetylcholinesteraseAnimalsInflammationPhenolsPlant ExtractsPoaceaeAcetylcholinesteraseButyrylcholinesterasePhenolsPlant ExtractsacetylcholinesteraseCymbopogon schoenanthushyaluronidaseneurodegenerationoxidative stressphenolic compounds

Identifiers

PMID36431805
PMCPMC9694793
OpenAlexW4308872175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.